© Springer International Publishing AG 2018
José Manuel Cameselle-Teijeiro, Catarina Eloy and Manuel Sobrinho-Simões (eds.)Rare Tumors of the Thyroid Glandhttps://doi.org/10.1007/978-3-319-61182-2_11. Introduction
Manuel Sobrinho-Simões1, 2, 3, 4 , Catarina Eloy1, 2, 3 , Isabel Amendoeira1, 4 , Paula Soares1, 2, 3 , Javier Caneiro-Gómez5 , Miguel Melo1, 2, 6, 7 and José M. Cameselle-Teijeiro8, 9
(1)
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
(2)
i3S – Instituto de Investigação e Inovação em Saúde, Porto, Portugal
(3)
Department of Pathology, Medical Faculty, University of Porto, Porto, Portugal
(4)
Department of Pathology, Hospital S. João, Porto, Portugal
(5)
Department of Pathology, Hospital Lucus Augusti, Galician Healthcare Service (SERGAS), Lugo, Spain
(6)
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
(7)
Unit of Endocrinology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
(8)
Department of Pathology, Clinical University Hospital, Galician Healthcare Service (SERGAS), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
(9)
Medical Faculty, University of Santiago de Compostela, Santiago de Compostela, Spain
We think this is the right time to publish a book on rare tumours of the thyroid gland for a number of reasons.
The fourth edition of the WHO classification of thyroid tumours is scheduled to appear still in 2017 [1], 13 years after the third edition. During this period, it was possible to evaluate the relative frequency of the so-called rare tumours of the thyroid, to identify some new ones and to incorporate in the description of most of them, additional molecular data at both the immunohistochemical and the genetic level.